Palisade Bio Inc
NASDAQ:PALI

Watchlist Manager
Palisade Bio Inc Logo
Palisade Bio Inc
NASDAQ:PALI
Watchlist
Price: 0.7014 USD 13.62% Market Closed
Market Cap: 3.4m USD

Intrinsic Value

PALI doesn't have a meaningful market cap.
PALI's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one PALI stock under the Base Case scenario is 2.5185 USD. Compared to the current market price of 0.7014 USD, Palisade Bio Inc is Undervalued by 72%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PALI Intrinsic Value
2.5185 USD
Undervaluation 72%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Palisade Bio Inc

Valuation History Unavailable

Historical valuation for PALI cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare PALI to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PALI?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Palisade Bio Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Palisade Bio Inc

Current Assets 10.5m
Cash & Short-Term Investments 9.8m
Receivables 24k
Other Current Assets 649k
Non-Current Assets 386k
PP&E 87k
Other Non-Current Assets 299k
Efficiency

Free Cash Flow Analysis
Palisade Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Palisade Bio Inc

Revenue
0 USD
Operating Expenses
-14.9m USD
Operating Income
-14.9m USD
Other Expenses
421k USD
Net Income
-14.4m USD
Fundamental Scores

PALI Profitability Score
Profitability Due Diligence

Palisade Bio Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

19/100
Profitability
Score

Palisade Bio Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

PALI Solvency Score
Solvency Due Diligence

Palisade Bio Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
57/100
Solvency
Score

Palisade Bio Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PALI Price Targets Summary
Palisade Bio Inc

There are no price targets for PALI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Palisade Bio Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PALI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PALI Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PALI stock?

The intrinsic value of one PALI stock under the Base Case scenario is 2.5185 USD.

Is PALI stock undervalued or overvalued?

Compared to the current market price of 0.7014 USD, Palisade Bio Inc is Undervalued by 72%.

Back to Top